'10,000 Immunomes' database opens a window on healthy immunity

October 9, 2018, University of California, San Francisco

Scientists at UC San Francisco have painstakingly assembled a searchable database of normal human immunity that researchers can now use as an instant comparison group in studies of the immune system and immune dysfunction. The new open-access data tool, called the 10,000 Immunomes Project (10KIP), pieces together the results of 83 studies that contain measurements on healthy people of various ages and backgrounds.

The database contains measurements from normal, healthy individuals enrolled in control groups for studies of organ transplantation, autoimmune disease trials, vaccine studies and other work funded by the National Institute of Allergy and Infectious Diseases (NIAID) that were uploaded to a preexisting data portal called ImmPort. The data, which can be found at http://10kimmunomes.org/, is available for free and comes with a visualization tool to help interpret results. The work is described in a paper published Tuesday, Oct. 9, 2018, in Cell Reports.

"I'm a big proponent of open data, and my lab has been working for years with Northrop Grumman and NIAID to disseminate immunology data through ImmPort," said senior author Atul Butte, MD, Ph.D., the Priscilla Chan and Mark Zuckerberg Distinguished Professor and director of the Bakar Computational Health Sciences Institute at UCSF (BCHSI). "We realized we had so much data, and especially we had so many control group individuals—healthy folks with no disease, who were treated with placebo or no drug at all—that we could now get a broad survey of what a normal healthy immune system looks like from all these individuals."

The research team pored through 242 studies that had uploaded their data to ImmPort to find measurements on , and then "harmonized" the measurements from the 83 relevant studies to overcome differences that arise from making measurements at different times and places, or from using different procedures.

"We found we could compensate for these artifacts with algorithms that had been developed for that purpose in computational genetics," said Kelly Zalocusky, Ph.D., first author of the study, who did the work when she was a postdoctoral scholar at BCHSI. Currently, she is a staff scientist at the Gladstone Institutes, an independent research organization that is academically affiliated with UCSF.

The data is rich enough that the researchers were able to create a custom of women between 18 and 40 years old to compare against 56 pregnant participants who had taken part in a study of the immune changes that take place in pregnancy. This enabled them to see how various immune cells and cell signaling proteins, known as cytokines, changed from pre-pregnancy levels, measurements that the original study lacked.

The researchers also used the data to compare immunity in men and women, over the life span and among people of diverse racial and ethnic backgrounds. They found the data reproduced known differences between men and women, and between people of different ages, while revealing new findings by race that could only be seen by combining data from dozens of different studies.

For example, they found that "natural killer cells," which kill tumor cells and cells infected by viruses, are found at lower levels in Asians than in whites. And regulatory T cells, which suppress immune responses, are present at higher levels in African American subjects, compared to all other groups.

The effort comes amid several high-profile announcements about open data, including the Vivli project to share , and Google's new search engine for .

"The ideal is still to recruit and collect measurements on immunity from large cohorts of people, such as what is proposed in the new UCSF Bakar ImmunoX project, but that will still take a lot of time and resources to complete," Butte said. "Since this data is already available, we want people to make use of it and help their science today. We expect that, as more scientists upload their to NIAID's ImmPort database, the power of 10KIP will only grow in value, richness and scale."

Explore further: Genetic control of human thymic function: A needle in an haystack

Related Stories

Genetic control of human thymic function: A needle in an haystack

September 5, 2018
A study conducted by a group of researchers from Paris Diderot University, INSERM and the Institut Pasteur reveals the existence of a genetic factor influencing the function of the human thymus. The results of the study, ...

During HIV infection, antibody can block B cells from fighting pathogens

August 13, 2018
For the first time, scientists have shown that in certain people living with HIV, a type of antibody called immunoglobulin G3 (IgG3) stops the immune system's B cells from doing their normal job of fighting pathogens. This ...

Researchers using big data to predict immunotherapy responses

August 8, 2018
In the age of Big Data, cancer researchers are discovering new ways to monitor the effectiveness of immunotherapy treatments.

Study identifies genes linked to better immune response to flu vaccine

August 25, 2017
Yale experts and their partners in a national research consortium have identified several genes and gene clusters associated with the immune response to flu vaccination. The findings point to the prospect of using genetic ...

Scientists discover biomarker for flu susceptibility

June 13, 2018
Researchers at the Stanford University School of Medicine have found a way to predict whether someone exposed to the flu virus is likely to become ill.

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.